1. Home
  2. BBIO vs SLM Comparison

BBIO vs SLM Comparison

Compare BBIO & SLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • SLM
  • Stock Information
  • Founded
  • BBIO 2015
  • SLM 1972
  • Country
  • BBIO United States
  • SLM United States
  • Employees
  • BBIO N/A
  • SLM N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • SLM Finance: Consumer Services
  • Sector
  • BBIO Health Care
  • SLM Finance
  • Exchange
  • BBIO Nasdaq
  • SLM Nasdaq
  • Market Cap
  • BBIO 5.1B
  • SLM 4.6B
  • IPO Year
  • BBIO 2019
  • SLM N/A
  • Fundamental
  • Price
  • BBIO $26.49
  • SLM $27.79
  • Analyst Decision
  • BBIO Strong Buy
  • SLM Buy
  • Analyst Count
  • BBIO 13
  • SLM 10
  • Target Price
  • BBIO $47.92
  • SLM $27.10
  • AVG Volume (30 Days)
  • BBIO 2.7M
  • SLM 3.5M
  • Earning Date
  • BBIO 11-12-2024
  • SLM 01-22-2025
  • Dividend Yield
  • BBIO N/A
  • SLM 1.87%
  • EPS Growth
  • BBIO N/A
  • SLM 117.36
  • EPS
  • BBIO N/A
  • SLM 2.91
  • Revenue
  • BBIO $217,765,000.00
  • SLM $1,586,141,000.00
  • Revenue This Year
  • BBIO $2,648.47
  • SLM N/A
  • Revenue Next Year
  • BBIO N/A
  • SLM $7.55
  • P/E Ratio
  • BBIO N/A
  • SLM $9.57
  • Revenue Growth
  • BBIO 2209.77
  • SLM 46.87
  • 52 Week Low
  • BBIO $21.62
  • SLM $18.04
  • 52 Week High
  • BBIO $44.32
  • SLM $28.24
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 49.05
  • SLM 63.32
  • Support Level
  • BBIO $25.34
  • SLM $26.64
  • Resistance Level
  • BBIO $28.15
  • SLM $27.40
  • Average True Range (ATR)
  • BBIO 1.33
  • SLM 0.75
  • MACD
  • BBIO -0.24
  • SLM -0.04
  • Stochastic Oscillator
  • BBIO 24.73
  • SLM 81.42

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About SLM SLM Corporation

SLM Corp is the largest student lender in the country. It makes and holds student loans through the guaranteed Federal Family Education Loan Program as well as through private channels. It also engages in debt-management operations, including accounts receivable and collections services, and runs college savings programs.

Share on Social Networks: